Faeth Therapeutics
Clinical trials sponsored by Faeth Therapeutics, explained in plain language.
-
New hope for advanced breast cancer: drug combo trial launches
Disease control Recruiting nowThis study tests two experimental drugs, sapanisertib and serabelisib, combined with other therapies for people with HR+/HER2- advanced or metastatic breast cancer. The goal is to find safe doses and see if the combinations shrink tumors. About 32 participants will join this earl…
Phase: PHASE1, PHASE2 • Sponsor: Faeth Therapeutics • Aim: Disease control
Last updated May 26, 2026 04:44 UTC
-
New drug combo shows promise for Tough-to-Treat endometrial cancer
Disease control Recruiting nowThis study tests a new combination of drugs (sapanisertib and serabelisib, called PIKTOR) plus chemotherapy (paclitaxel) in people with advanced or recurrent endometrial cancer that has not been cured by prior treatments. About 40 participants will receive the drug combo, and a s…
Phase: PHASE2 • Sponsor: Faeth Therapeutics • Aim: Disease control
Last updated May 13, 2026 16:03 UTC